BioSpace News Archive

LadRx Corporation announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday, October 6, 2022.

BIOQUAL, Inc., Announces Promotion of Mr. Charles C. Kirk, Jr., CPA. to the Position of Chief Financial Officer.

ONWARD Medical N.V. reported topline results from the LIFT Home study, evaluating the safety and feasibility of ARC-EX Therapy when used at home.

SpineX, Inc., a clinical stage medtech company announced the groundbreaking results its first in human study in children with cerebral palsy.

Prokarium Ltd, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced the receipt of a Notice of Allowance from the United States Patent and Trademark Office.

InDex Pharmaceuticals Holding AB announced that the company will be exhibiting at the United European Gastroenterology Week October 8-11, 2022 in Vienna.

I-Mab today announced that the Company will present new preclinical data of its core assets lemzoparlimab and uliledlimab, respectively, at the 37th Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in Boston, MA, as well as virtually November 8-12, 2022.

Eiger BioPharmaceuticals, Inc. today announced that, following feedback from the U.S. Food and Drug Administration (FDA), the company will not submit an emergency use authorization (EUA) application of peginterferon lambda for the treatment of patients with mild-to-moderate COVID-19.

AbCellera (Nasdaq: ABCL) today announced a presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at the Boston Convention & Exhibition Center from November 8 to 12, 2022.

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the acceptance of two abstract for poster presentations at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, which is taking place both virtually and in-person at the Boston Convention and Exhibition Center in Boston, MA, from November 8 – 12, 2022.